I think this company are very adept at adjusting their strategy
according to ongoing developments in their business and in the
current environment. If they see an opportunity to improve any
situation, they have the flexibility and foresight to take it up.
I believe this is a very important and favorable aspect of their
performance as a company.
Ann: Imugene Licenses Allogeneic CD19 CAR T Cell Therapy, page-480
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.001(1.89%) |
Mkt cap ! $389.5M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.4¢ | 5.3¢ | $54.78K | 1.033M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 627915 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 3080851 | 14 |
View Market Depth
| Last trade - 10.04am 16/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |